Quent Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.8K Buy
5,139
+5,010
+3,884% +$37.7K ﹤0.01% 867
2025
Q4
$922 Sell
129
-960
-88% -$7.58K ﹤0.01% 1471
2025
Q3
$11.6K Buy
+1,089
New +$10.7K ﹤0.01% 980
2025
Q2
Sell
-818
Closed -$12.2K 947
2025
Q1
$12.2K Buy
818
+77
+10% +$1.18K ﹤0.01% 870
2024
Q4
$11K Sell
741
-137
-16% -$2.23K ﹤0.01% 914
2024
Q3
$16.8K Buy
878
+83
+10% +$1.72K ﹤0.01% 917
2024
Q2
$16.5K Sell
795
-69
-8% -$1.37K ﹤0.01% 901
2024
Q1
$16.3K Sell
864
-6
-0.7% -$103 ﹤0.01% 931
2023
Q4
$12.5K Buy
870
+376
+76% +$5.12K ﹤0.01% 931
2023
Q3
$8.57K Sell
494
-294
-37% -$6.13K ﹤0.01% 963
2023
Q2
$16.4K Buy
788
+1
+0.1% +$22 ﹤0.01% 828
2023
Q1
$18.5K Buy
787
+31
+4% +$832 ﹤0.01% 793
2022
Q4
$21.1K Sell
756
-728
-49% -$18.6K ﹤0.01% 761
2022
Q3
$35K Buy
1,484
+16
+1% +$483 0.01% 634
2022
Q2
$50K Sell
1,468
-11
-0.7% -$385 0.01% 520
2022
Q1
$52K Sell
1,479
-292
-16% -$9.99K 0.01% 584
2021
Q4
$54K Buy
+1,771
New +$57.7K 0.01% 525

Other funds holding OGN

Quent Capital's OGN Position: Q1 2026 in Review

Quent Capital increased its Organon & Co (OGN) stake by 3,884% in Q1 2026, buying an estimated $37.7K and bringing the position to 5,139 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

Quent Capital first reported a position in OGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $54K in Q4 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Quent Capital held 5,139 shares of Organon & Co worth $30.8K as of Q1 2026.
  • Quent Capital bought 5,010 Organon & Co shares in Q1 2026, an estimated $37.7K.
  • Organon & Co made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #867 holding.
  • Quent Capital first reported a position in Organon & Co in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Organon & Co position peaked at $54K in Q4 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.